SRC and prostate adenocarcinoma: The cancer genome atlas (TCGA) via the GEPIA database showed that SRC expression was significantly upregulated in the tumor part of LIHC (T/N = 369/160) compared to COAD (colon adenocarcinoma, T/N = 275/349), PRAD (prostate adenocarcinoma, T/N = 492/152), GBM (glioblastoma multiforme, T/N = 163/207), and LUAD (lung adenocarcinoma, T/N = 483/347) (Figure 4C).